Apagie has helped numerous New Zealand businesses expand their reach into international markets. One such client is a pioneer in spectral molecular imaging who had developed an advanced medical diagnostic imaging technology but lacked a clear view of its best commercial application.
Apagie worked closely with the client, guiding them through four cycles of our market research and validation process, culminating in a successful commercial partnership with the largest orthopedic hospital in the US, validation of the US market opportunity, and a pipeline of interested hospitals.
The client was faced with several challenges, having developed an advanced medical diagnostic imaging technology.
They lacked a clear view of its best commercial application and did not know if the market cared about the technology. They were unaware of the size of the problem the technology solved and didn't know how to sell to complex organizations.
The client wasn't familiar with the US healthcare reimbursement system and lacked a strategy to commercialize their technology.They also needed help developing a business model for global growth.
Apagie's approach involved four cycles of market research and validation, strategy, and execution. We helped our client validate reimbursement assumptions and strategy, researching the US medical insurance system to advise strategy for reimbursement of the use of technology, informing the sales proposition.
Apagie's approach helped the client establish a commercial partnership with the largest orthopedic hospital in the US.
We validated the US market opportunity, generated a pipeline of interested hospitals, developed a commercial strategy, and shaped a significant capital raise.
Working with Apagie, the client successfully overcame the challenges they were facing, achieved their business goals, and positioned themselves for long-term success.